Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/02/21
End: 08/15/25
Due: 08/15/26
Phase: N/A
Priority: Normal
Start: 10/10/19
End: 11/02/20
Due: 11/02/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS) | NCT05039099 | AL-S Pharma | user2@example.com | None | 2021-09-02 | 2025-08-15 | 2026-08-15 | - | - | 2025-07-14 |
| A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) | NCT03981536 | AL-S Pharma | user2@example.com | None | 2019-10-10 | 2020-11-02 | 2021-11-02 | - | - | 2025-07-14 |